It looks like Roundup maker Bayer might see the writing on the wall. After losing three attempts to convince juries that its flagship herbicide Roundup wasn’t causing customers to develop non-Hodgkin’s lymphoma, reports are surfacing of the corporation’s attempts to find a suitable amount to settle the matter.
Information leaked from those said to be familiar with the negotiations indicates that Bayer has offered up to $8 billion to ...
continue reading...